Technology of pharmaceutic powders: tablets produced using a special technology
Arecco, D.; Bassi, M.; Gabrielli, B.; Merlini, A.
Bollettino Chimico Farmaceutico 115(10): 680-701
1976
ISSN/ISBN: 0006-6648 PMID: 1016598 Document Number: 98280
Document emailed within 1 workday
Related Documents
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379Pan, Y.-P.; Zhang, Z.-H.; Jiang, Y.-R.; Jia, X.-B. 2013: Advances in studies on modification technology of traditional Chinese medicine powders Zhongguo Zhong Yao Za Zhi 38(22): 3808-3813
Hładoń, T. 1981: Physico-chemical studies on adsorptive properties of pharmaceutic aids used in pharmaceutical technology. II. Mechanism of adsorption of sulfonamides on Veegum Acta Poloniae Pharmaceutica 38(2): 229-235
Nakonieczny, D.; Walke, W.; Majewska, J.; Paszenda, Z. 2014: Characterization of magnesia-doped yttria-stabilized zirconia powders for dental technology applications Acta of Bioengineering and Biomechanics 16(4): 99-106
Briseid, G.; Arntzen, F.C. 1995: Factor VIIi preparation produced by recombinant DNA-technology is approved in Norway Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(15): 1849-1851
Bushra, R.; Rehman, A.; Ghayas, S.; Zafar, F.; Ali, H.; Shafiq, Y.; Khalid, F.; Khan, M.A.; Hanif, A.; Mustapha, O. 2018: Formulation design, characterization and optimization of cinitapride (1mg) immediate release tablets using direct compression technology Pakistan Journal of Pharmaceutical Sciences 31(6: 2725-2731
Boitte, P 2005: Between technology and humanity: the impact of technology on health care ethics Journal of Medical Ethics 31(1): E4-E4
Mock, K. 1993: Routine sensitive peptide mapping using LC/MS of therapeutic proteins produced by recombinant DNA technology Peptide Research 6(2): 100-104
Wamuyu, P Kanyi 2015: The Impact of Information and Communication Technology Adoption and Diffusion on Technology Entrepreneurship in Developing Countries: The Case of Kenya Information Technology for Development 21(2): 253-280
Rothman, B.K. 1998: Ideology and technology: the social context of procreative technology Mount Sinai Journal of Medicine new York 65(3): 201-209; Discussion: 215-223
1983: Technology. Joint model for local agreement on new technology Sygeplejersken 83(7): 20-3 28
Mikhaĭlitsyn, F.S.; Petrov, I.F.; Bol'shakova, A.I.; Lebedeva, M.N.; Lychko, N.D. 1995: The technology for manufacturing antiparasitic preparations. 4. the development of a technology for producing the anthelmintic bromoksan in finely dispersed form and the evaluation of its antifascioliasis activity Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 41-42
Wang, R.; Zhan, L.; Xu, Z.; Wang, R.; Wang, J. 2024: A green strategy for upcycling utilization of core parts from end-of-life vehicles (ELVs): Pollution source analysis, technology flowchart, technology upgrade Science of the Total Environment 912: 169609
Beach, S.R.; Schulz, R.; Matthews, J.T.; Courtney, K.; Dabbs, A.DeVito. 2014: Preferences for technology versus human assistance and control over technology in the performance of kitchen and personal care tasks in baby boomers and older adults Disability and Rehabilitation. Assistive Technology 9(6): 474-486
Thoma, K.; Heckenmüller, H. 1986: Thin layer chromatographic detection of emollients in gastric juice-resistant coatings. 2. the pharmaceutic technology and analysis of gastric juice-resistant dosage forms Die Pharmazie 41(5): 328-332
Hollenbach, K.; Pintye-Hódi, K.; Kedvessy, G. 1980: On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital a (modifications i and IIi and their release from tablets Die Pharmazie 35(1): 32-35
Guo, L.-p.; Huang, L.-q.; Lv, D.-m.; Shao, A.-j.; Wang, J. 2007: Construction and application of special analysis database of geoherbs based on 3S technology Zhongguo Zhong Yao Za Zhi 32(17): 1821-1824
Ueshima, S. 1989: Development of new thrombolytic enzymes by gene technology--with special references to t-PA, scu-PA, protein C Nihon Rinsho. Japanese Journal of Clinical Medicine 47(4): 901-909
Jastremski, M.; Jastremski, C.; Shepherd, M.; Friedman, V.; Porembka, D.; Smith, R.; Gonzales, E.; Swedlow, D.; Belzberg, H.; Crass, R. 1995: A model for technology assessment as applied to closed loop infusion systems. Technology Assessment Task Force of the Society of Critical Care Medicine Critical Care Medicine 23(10): 1745-1755
Mikhaĭlitsyn, F.S.; Drusviatskaia, S.K.; Uvarova, N.A.; Taits, S.Z.; Stoianovich, F.M.; Vol'kenshteĭn, I.B.; Lebedeva, M.N.; Krotov, A.I.; Lychko, N.D. 1994: The technology for manufacturing antiparasitic preparations. 3. the development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 24-26